1) The enzyme-mediated activation of radical source reaction: a new approach to identify partners of a given molecule
丂 in membrane microdomains.
丂 Honke K, Kotani N.
丂 J. Neurochem. 2011; 116: 690-695 (IF 4.337)

2) Spatiotemporally-regulated interaction between b1 integrin and ErbB4 that is involved in fibronectin-dependent cell
丂 migration.
丂 Yamashita R, Kotani N, Ishiura Y, Higashiyama S, Honke K.
丂 J. Biochem. 2011; (IF: 2.145)

3) Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth.
丂 Taniuchi K, Cerny RL, Tanouchi A, Kohno K, Kotani N, Honke K, Saibara T, Hollingsworth MA.
丂 Oncogene30: 4843-4854, 2011 (IF: 7.414)

4) A proteomics approach to the cell-surface interactome using the enzyme-mediated activation of radical sources
丂 reaction.
丂 Jiang S, Kotani N, Ohnishi T, Miyagawa-Yamguchi A, Tsuda M, Yamashita R, Ishiura Y, Honke K.
丂 Proteomics12:54-62, 2012 (IF: 4.815) 丂丂丂丂丂

5) Toward more accurate pan-specific MHC-peptide binding current methods and tools.
丂 Zhang L., Udaka K., Mamitsuka H., and Zhu S..
丂 Brief Bioinform2011 Sep 22.[Epub ahead of print]乮IF:9.283乯 丂丂丂丂丂

6) Identification and functional characterization of glioma-specific promoters and their application in suicide gene
丂 therapy.
丂 Yawata T, Maeda Y, Okiku M, Ishida E, Ikenaka K, Shimizu K.
丂 J Neurooncol. 2011;104(2):497-507

7) HA1077, a Rho kinase inhibitor, suppresses glioma-induced angiogenesis by targeting the Rho-ROCK and the mitogen
丂 -activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signal pathways.
丂 Nakabayashi H, Shimizu K.
丂 Cancer Sci. 2011;102(2):393-9. (IF 3.846)

8) Characterization of lytic enzyme open reading frame 9 (ORF9) derived from Enterococcus faecalis bacteriophage
丂 phiEF24C.
丂 Uchiyama J, Takemura I, Hayashi I, Matsuzaki S, Satoh M, Ujihara T, Murakami M, Imajoh M, Sugai M, Daibata M.
丂 Appl Environ Microbiol. 2011; 77:580-585 (IF: 3.686)

9) Presence of Merkel cell polyomavirus in Japanese cutaneous squamous cell carcinoma.
丂 Murakami M, Imajoh M, Ikawa T, Nakajima H, Kamioka M, Nemoto Y, Ujihara T, Uchiyama J, Matsuzaki S, Sano S,
丂 Daibata M.
丂 J Clin Virol. 2011; 50: 37-41 (IF: 3.124)

10) Genetic characterization of Pseudomonas aeruginosa bacteriophage KPP10.
丂 Uchiyama J, Rashel M, Takemura I, Kato SI, Ujihara T, Muraoka A, Matsuzaki S, Daibata M.
丂 Arch Virol. 2012 Apr;157(4):733-8 (IF 2.209) 丂

11) Improved adsorption of an Enterococcus faecalis bacteriophage兂EF24C with a spontaneous point mutation.
丂 Uchiyama J, Takemura I, Satoh M, Kato S, Ujihara T, Akechi K, Matsuzaki S, Daibata M.
丂 PLoS One. 2011;6(10) (IF 4.411) 丂

12) Safety and effectiveness of a new enzyme-targeting radiosensitization treatment (KORTUC II) for intratumoral
丂 injection for low-LET radioresistant tumors.
丂 Ogawa Y, Kubota K, Ue H, Tadokoro M, Matsui R, Yamanishi T, Hamada N, Kariya S, Nishioka A, Nakajima H,
丂 Tarutani M, Sano S.
丂 Int J Oncol. 2011 Sep;39(3):553-60. (IF 2.571)

挊彂

1) 杮壠岶堦
丂帀幙丆僇儔乕僀儔僗僩偱妛傇丂廤拞島媊丂惗壔妛丂乮楅栘宧堦榊丄杮壠岶堦丄戝壨尨抦悈丄摗尨斖巕曇挊乯pp.242-331丄
丂儊僕僇儖價儏乕幮丄搶嫗丄2011.2

2) 塅崅宐巕乮忋栰愳廋堦丒媑愳惓柧曇廤乯
丂怘偲寬峃偺偨傔偺柶塽妛擖栧丂丂戞10復丂偑傫偲儁僾僠僪儚僋僠儞丂p.177-198丄寶涘幮丄2012

3) 塅崅宐巕乮塱堜峆巌丒壀揷峅峎娔廋乯
丂僪儔僢僌僨儕僶儕乕僔僗僥儉偺怴揥奐俬俬丂乕妀巁堛栻丒峈懱堛栻傪巟偊傞俢俢俽媄弍乕丂儚僋僠儞傊偺揥奐丂4.
丂儁僾僠僪偑傫儚僋僠儞丂P.181-188丄僔乕僄儉僔乕弌斉丄2012

丂 戞4761311崋丂HLA寢崌惈儁僾僠僪丄偦偺慜嬱懱丄偦傟傪僐乕僪偡傞DNA抐曅偍傛傃慻傒姺偊儀僋僞乕
丂 敪柧幰丗媨愳抦栫丄塅崅宐巕丂暯惉23擭6寧17擔

弌婅

1) 摿婅2011-273922, 僿儖僷乕俿嵶朎桿摫惈億儕儁僾僠僪偺夵曄
丂 塅崅宐巕丂暯惉23擭12寧14擔

2) 摿婅2011-192996, 墿怓僽僪僂媴嵶嬠偵寢崌偡傞僞儞僷僋幙媦傃偦偺僞儞僷僋幙傪棙梡偟偨墿怓僽僪僂媴嵶嬠偺應掕曽朄
丂 戝敤夒揟丄徏嶈栁揥丄撪嶳弤暯丄抾懞埳戙丂暯惉23擭9寧5擔

1) Honke K, Miyagawa-Yamaguchi A, Kotani N.
丂 Analysis of molecular clustering on the living cell membrane, Glycobiology Japan-Netherland Joint Seminar 2011
丂Oct 8-11, 2011, Nagoya, Japan

2) Jumpei Uchiyama, Iyo Takemura, Miho Satoh, Shin-ichiro Kato, Takako Ujihara, Kazue Akechi, Shigenobu Matsuzaki,
丂Masanori Daibata.
丂 Improved adsorption of Enterococcus faecalis bacteriophage 冇EF24C caused by a point mutation in a tail fiber.
丂 International Union of Microbiological Societies 2011 Cngress (Sapporo). XV. International Congress of Virology.
丂 September 11-16, 2011.

3) Iyo Takemura, Jumpei Uchiyama, Miho Satoh, Shin-ichiro Kato, Takako Ujihara, Shigenobu Matsuzaki,Tetsuro
丂Sugiura,Masanori Daibata.
丂 Identification of a tail adsorption protein by comparative genomic analysis of Staphylococcus aureus bacteriophages
丂S13乫 and S24-1.
丂 International Union of Microbiological Societies 2011 Cngress (Sapporo). XV. International Congress of Virology.
丂 September 11-16, 2011.

崙撪妛夛

1) 杮壠岶堦
丂暘巕偺娽傪媮傔偰
丂崅抦戝妛僀僲儀乕僥傿僽儅儕儞僥僋僲儘僕乕尋媶幰堢惉帠嬈丒摑崌揑僶僀僆僀儊乕僕儞僌尋媶幰堢惉帠嬈崌摨僔儞億僕僂儉
丂乽戞2夞揤慠暔壔妛偺怴揥奐乿丆2011擭7寧2擔丆崅抦

2) 杮壠岶堦丄彫扟揟峅
丂 EMARS斀墳丂乕惗偒偰偄傞嵶朎偺昞柺偱擟堄偺暘巕偲夛崌偡傞暘巕傪摨掕偡傞乕
丂戞61夞擔杮揹婥塲摦妛夛乮JES乯僔儞億僕僂儉乛戞7夞擔杮椪彴僾儘僥僆乕儉尋媶夛乮JSCP乯2011楢崌戝夛
丂2011擭5寧9-10擔丄嶳岥

3) 杮壠岶堦
丂棸巁壔摐嵔偺惗棟婡擻丏堚揱巕丒僨儕僶儕乕尋媶夛戞11夞壞婜僙儈僫乕丄2011擭8寧8-9擔丄崅抦

4) 塅崅宐巕
丂乬How丂do T cells find their way into solid tumors?乭 擔杮偑傫柶塽妛夛乮僔儞億僕僂儉乯
丂2011.6.30-7.1丂朙拞巗丂愮棦儔僀僼僒僀僄儞僗僙儞僞乕

5) 塅崅宐巕
丂乽埆惈庮釃偺儁僾僠僪柶塽椕朄丂乕側傝偨偪偲揥朷乕乿 擔杮慻怐揔崌惈妛夛嬤婨抧曽夛
丂2012.2.5丂戝嶃巗丂嶲揤惢栻姅幃夛幮杮幮

6) 徏嶈栁揥丄撪嶳弤暯丄撪嶳乮抾懞乯埳戙丄戝敤夒揟
丂 僶僋僥儕僆僼傽乕僕偺旜晹儕僈儞僪暘巕傪棙梡偡傞嵶嬠摨掕朄 崙嵺堛栻昳尨椏丒拞娫懱揥 2012 (CPhIJAPAN2012)
丂 2012擭俁寧21-23擔丂 搶嫗

7) 彫愳嫳峅
丂 嵟嬤偺曻幩慄帯椕偺恑曕偲怴偟偄憹姶曻幩慄椕朄KORTUC丄戞係夞丂恄屗偑傫尋媶夛
丂 2011擭6寧24擔丂恄屗巗

8) 彫愳嫳峅
丂 嵟嬤偺曻幩慄帯椕偺恑曕偲怴偟偄憹姶曻幩慄椕朄KORTUC丄戞俇夞丂杒戝嶃Radiology僇儞僼傽儗儞僗
丂2011擭10寧7擔丂崅捨巗

9) 彫愳嫳峅
丂 怴偟偄憹姶曻幩慄椕朄KORTUC偺嶌梡儊僇僯僘儉偲椪彴墳梡偺尰嫷丄戞俉夞丂拞晹曻幩慄帯椕尋媶夛妛弍島墘夛
丂柤屆壆巗

曬摴

彫愳嫳峅
丂Medical Tribune 2011擭10寧27擔崋丄15儁乕僕
丂峺慺昗揑丒憹姶曻幩慄椕朄KORTUC II乣椙岠偵擕朳壏懚

1) What should the targeted range of blood glucose levels be to reduce the incidence of surgical site infection following
丂 general surgery?
丂 Hanazaki K, Okabayashi T.
丂 Arch Surg. 2011, 146(3):368-369. (IF: 4.50)

2) What is the best way to guarantee postoperative glycemic control?
丂 Hanazaki K, Munekage M, Okabayashi T.
丂 J Am Coll Surg. 2011, 212(5): 915-916 (IF: 4.241)

3) Continuous monitoring of glucose levels in the hepatic vein and systemic circulation during the Pringle maneuver in
丂 beagles.
丂 Yatabe T, Kitagawa H, Kawano T, Munekage M, Okabayashi T, Yamashita K, Hanazaki K, Yokoyama M.
丂 J Artif Organs. 2011 Sep;14(3):232-237 (IF: 1.488)

4) Long-term disease-free postoperative survival after combined vascular resection of hilar cholangiocarcinoma.
丂 Maeda H, Okabayashi T, Machida T, Shimada K, Kajikawa S, Amano J, Hanazaki K.
丂 Am Surg. 2011 May; 77(5):82-84. (IF: 1.363)

5) Determination of the optimal perioperative blood glucose level to reduce surgical site infection in diabetic patients.
丂 Hanazaki K, Kitagawa H, Okabayashi T.
丂 J Am Coll Surg. 2011; 213(1): 198-199. (IF: 4.241)

6) Pancreatogenic diabetes after pancreatic resection.
丂 Maeda H, Hanazaki K.
丂 Pancreatology. 2011;11(2):268-276. (IF: 2.128)

7) Progressive artificial endocrine pancreas: The era of novel perioperative blood glucose control for surgery.
丂 Tsukamoto Y, Okabayashi T, Hanazaki K.
丂 Surg Today 2011; 41(10): 1344-1351. (IF: 1.057)

8) Blood glucose control using an artificial pancreas reduces the workload of ICU nurses.
丂 Mibu K, Yatabe T, Hanazaki K.
丂 J Artif Organs. 2012 Mar;15(1):71-76. Epub 2011 Sep 27. (IF: 1.488)

9) What is the optimal blood glucose range to improve morbidity and mortality in surgical patients?
丂 Hanazaki K, Munekage M, Okabayashi T.
丂 Ann Surg. 2011; 254(4):671-672. (IF: 7.474)

10) Effect of perioperative intensive insulin therapy for liver dysfunction after hepatic resection.
丂 Okabayashi T, Ichikawa K, Namikawa T, Sugimoto T, Kobayashi M, Hanazaki K.
丂 World J Surg. 2011 Dec;35(12):2773-2778 (IF: 2.693)

11) Effect of perioperative intensive insulin therapy for liver dysfunction after hepatic resection.
丂 Okabayashi T, Ichikawa K, Okamoto K, Dabanaka K, Namikawa T, Sugimoto T, Kobayashi M, Hanazaki K.
丂 Hepatogastroenterology. 2011; 58(Suppl II): 68. (IF: 0.677)

12) High-mobility group box 1 are decreased in patients undergoing liver surgery for sivelestat sodium hydrate.
丂 Ichikawa K, Okabayashi T, Okamoto K, Dabanaka K, Namikawa T, Sugimoto T, Kobayashi M, Hanazaki K.
丂 Hepatogastroenterology. 2011; 58(Suppl II): 51. (IF: 0.677)

13) The effect of the neutrophil elastase inhibitor sivelestat on early injury after liver resection.
丂 Tsujii S, Okabayashi T, Shiga M, Takezaki Y, Sugimoto T, Kobayashi M, Hanazaki K.
丂 World J Surg. 2012 May;36(5):1122-1127 (IF: 2.693)

14) Surgery for gastroenteropancreatic neuroendocrine tumor (GEPNET) in multiple endocrine neoplasia type 1.
丂 Hanazaki K, Sakurai A, Munekage M, Ichikawa K, Namikawa T, Okabayashi T, Imamura M.
丂 Surg Today. 2012, in press (IF: 1.057)

15) Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicenter database.
丂 Sakurai A, Suzuki S, Kosugi S, Okamoto T, Uchino S, Miya A, Imai T, Kaji H, Komoto I, Miura D, Yamada M, Uruno T,
丂 Horiuchi K, Miyauchi A, Imamura M; MEN Consorium of Japan, Fukushima T, Hanazaki K, Hirakawa S, Igarashi T,
丂 Iwatani T, Kammori M, Katabami T, Katai M, Kikumori T, Kiribayashi K, Koizumi S, Midorikawa S, Miyabe R,
丂 Munekage M, Ozawa A, Shimizu K, Sugitani I, Takeyama H, Yamazaki M.
丂 Clin Endocrinol (Oxf). 2012 Apr 76(4): 533-539. (IF: 3.323)

16) Possible involvement of intracellular angiotensin 嘦 receptor in high-glucose-induced damage in renal proximal
丂 tubular cells丏
丂
丂 Takao T, Horino T, Kagawa T, Matsumoto R, Shimamura Y, Ogata K, Inoue K, Taniguchi Y, Taguchi T, Morita T,
丂 Terada Y.
丂 Journal of Nephrology 24(03)丗 218-224丆 2011丏 (IF: 1.623)

17) Rapidly progressive destructive arthritis in psoriatic arthritis sine psoriasis丗 do bone resorption marker levels predict
丂 outcome of bone destruction in psoriatic arthritis?丏
丂
丂 Taniguchi Y, Kumon Y, Shimamura Y, Kobayashi S, Terada Y.
丂 Mod Rheumatol. 21丗106-108丆 2011丏 (IF: 1.800)

18) Weber-Christian disease associated with granulomatous mastitis a variant type of Weber-Christian disease?
丂
丂 Taniguchi Y, Kagawa T, Ishibashi A, Horino T, Kumon Y, Terada Y.
丂 Mod Rheumatol. 21丗228-231丆 2011丏 (IF: 1.800)

19) Atypical generalized morphea-like scleroderma presenting deep sclerosis on the fingers.
丂
丂 Taniguchi Y, Okazaki M, Kagawa T, Nakajima K, Nakajima H, Terada Y.
丂 Mod Rheumatol. 21丗232-234丆 2011丏 (IF: 1.800)

20) F-18 FDG PET/CT provides the earliest findings of enthesitis in reactive arthritis.
丂
丂 Taniguchi Y, Kumon Y, Nakayama S, Arii K, Ohnishi T, Ogawa Y, Kobayashi S, Terada Y.
丂 Clin Nucl Med. 36丗121-123丆 2011丏 (IF: 3.766)

21) Aldosterone Stimulates NF-kB Activity and Transcription of ICAM-1 and CTGF in Rat Mesangial Cells via SGK(Serum
丂 and Glucocorticoid-inducible Protein Kinase)-1丏
丂
丂 Terada Y, Ueda S, Hamada K, Shimamura Y, Ogata K, Inoue K, Taniguchi Y, Kagawa T, Horino T, Takao T.
丂 Clinical and Experimental Nephrology. 2012 Feb;16(1):81-88丏 (IF: 3.766)

22) Corticotropin-releasing hormone(CRH) transgenic mice display hyperphagia with increased Agouti-related protein
丂 mRNA in the hypothalamic arcuate nucleus.
丂
丂 Nakayama S, Nishiyama M, Iwasaki Y, Shinahara M, Okada Y, Tsuda M, Okazaki M, Tsugita M, Tagichi T, Makino S,
丂 Stenzel-Poore MP, Hashimoto K, Terada Y.
丂 Endocrine Journal. 58丗279-286丆2011. (IF: 1.952)

23) Giant Pelvic Calcification.
丂
丂 Taguchi T, Maeda N, Fukuya T, Terada Y.
丂 Internal Medicine. 50丗2687-2688丆2011丏(IF: 1.037)

24) Hepatic arteriovennous malformation with hyperammonemia in Rendu-Osler-Weber syndrome丏
丂
丂 Taguchi T, Iwamura S, Mizobuchi M, Terada Y.
丂 J Gastrointestinal Liver Dis 20丗330-331丆2011丏(IF: 1.434)

25) Callus Formation in a Patient with Cushing乫s Syndrome.
丂
丂 Taguhi T, Ishibashi A, Shuin T, Terada Y.
丂 Internal Medicine. 50丗1861-1862丆2011丏(IF: 1.037)

26) Giant Adrenal Calcification.
丂
丂 Taguchi T, Inoue K, Shuin T, Terada Y.
丂 Internal Medicine. 50丗1781丆2011丏(IF: 1.037)

27) Ramsay-Hunt syndrome.
丂
丂 Taguchi T, Ueda S, Kudo T, Nakajima H, Nishioka R, Sano S, Terada Y.
丂 Journal of Infection. 62丗180-181丆2011丏(IF: 3.805)

28) Secondary Retroperitoneal Fibrosis Due to Polyarteritis Nodosa Evaluated by F-18 FDG PET/CT丏
丂
丂 Tanigchi Y丆Kumon Y丆Kagawa T丆Terada Y.
丂 Clinical Nuclear Medicine. 36丗1044-1045丆2011丏(IF: 3.766)

29) Plasma Dehydroepiandrosterone Sulfate and Insulin-like Growth Factor I Levels in Obstructive Sleep
丂 ApneaSyndrome丏
丂
丂 Makino S丆Fujiwara M丆Handa H丆Fujie T丆Aoki Y丆Hashimoto K丆Terada Y丆Sugimoto T.
丂 Clin Endocrinol. 76:593-601, 2012 (IF: 3.323)

30) (18)FDG PET乛CT is a powerful tool for detecting subclinical arthritis in patients with psoriatic arthritis and乛or
丂 psoriasis vulgaris.
丂
丂 Takata T, Taniguchi Y, Ohnishi T, Kohsaki S, Nogami M, Nakajima H, Kumon Y, Terada Y, Ogawa Y,Tarutani M,
丂 Sano S.
丂 J Dermatol Sci. 64丗144-147丆2011丏 (IF: 3.712)

31) Aldosterone Stimulates nuclear factor-kappa B activity and Transcription of intercellular adhesion molecule-1 and
丂 connective tissue growth factor in rat mesangial cells via serum-and glucocorticoid-inducible protein kinase-1丏
丂
丂 Terada Y, Ueda S, Hamada K, Shimamura Y, Ogata K, Inoue K, Taniguchi Y, Kagawa T, Horino T, Takao T.
丂 Clin Exp Nephrol. 16:81-88丆2012丏(IF: 1.460)

1) Hanazaki K, Maeda H, Munekage M, Ichikawa K, Kitagawa H, Namikawa T, Sugimoto T, Kobayashi M, Okabayashi T.
丂 Continuous blood glucose monitoring using an artificial pancreas during hepatic ischemia-reperfusion period in
丂 patients undergoing hepatic resection. 8th Asian Congress for Microcirculation (ACM)
丂 MEDIMOND international proceedings 2011:123-126.

2) 廆宨嫥嵠丄壴�睒a峅 丂
丂 嵟怴僀儞僗儕儞椕朄丄恖岺鋁搰偵傛傞廃弍婜偺寣摐娗棟(active from expert) 丂
丂 137-139暸丄峳栘塰堦丄怐揷桾岶乮曇乯丄拞嶳彂揦丄搶嫗丄2011.

3) 搰懞朏巕丄帥揷揟惗 丂
丂 僼傽儞僐僯徢岓孮 丂
丂 徢岓孮僴儞僪僽僢僋丄戞嘯復倫467丏拞嶳彂揦 2011丏

4) 怷揷払恗丄帥揷揟惗 丂
丂 寣擜丄嬞媫搙丒廳徢搙偐傜傒偨徢忬暿娕岇夁掱+昦懺娭楢恾 丂
丂 p918-923丏堛妛彂堾2011丏

5) 忋揷孭巕丄堜忋崃棟丄搰懞朏巕丄弿曽岻擇丄帥揷揟惗 丂
丂 怴偟偄摐擜昦栻偺CKD偱偺壜擻惈 丂
丂 撪壢vol.107(2)丗271-275丆2011丏

6) 帥揷揟惗丄忋揷孭巕丆愇尨惓峴丆搰懞朏巕丆弿曽岻擇 丂
丂 擜嵶娗偺忈奞偲嵞惗 丂
丂 恡偲摟愅vol.70乮2乯丗262-266丆2011.

7) 弿曽岻擇丄郷揷壚庻丄忋揷孭巕丄搰懞朏巕丄堜忋峢曘丄扟岥媊揟丄崄愳丂嫓丄帥揷揟惗 丂
丂 憙忬巺媴懱峝壔徢丂亅昦場偐傜帯椕傑偱亅 丂
丂 椪喱偲尋媶丂戞88姫戞4崋丗491-496丆2011丏

8) 堜忋峢曘丄弿曽岻擇丄搰懞朏巕丄崄愳丂嫓丄帥揷揟惗 丂
丂 媫惈恡忈奞偵偍偗傞擜拞僶僀僆儅乕僇乕偺尰忬 丂
丂 恡偲摟愅vol.70乮3乯丗339-341丆2011丏

9) 搰懞朏巕丄帥揷揟惗 丂
丂 崅楊幰偲恡忈奞 丂
丂 Renin Academy Japan Journal No.7丗14-15丆2011丏

10) 弿曽岻擇丄搰懞朏巕丄堜忋峢曘丄崄愳丂嫓丄帥揷揟惗 丂
丂 扽巁扙悈峺慺慾奞栻丄怹摟埑棙擜栻丄僶僜僾儗僢僔儞漢峈栻乮椪彴堛偑抦偭偰偍偔傋偒偙偲丄彨棃惈傪娷傔偰乯 丂
丂 Modern Physician Vol.31乮6乯丗731-733丆2011丏

11) 弿曽岻擇丄忋揷孭巕丄搰懞朏巕丄堜忋峢曘丄崄愳丂嫓丄帥揷揟惗 丂
丂 懡敪惈崪悜庮偲恡忈奞 丂
丂 憥崌椪喱vol.60乮6乯丗1421-1424丆2011丏

12) 岞暥媊梇丄悪塝揘楴丄扟岥媊揟丄帥揷揟惗丄桳堜丂孫丄彫椦栁恖 丂丂丂丂丂丂丂
丂 愐捙娭愡墛偵偍偗傞FDG-PET/CT偺桳梡惈 丂
丂 擔杮愐捙娭愡墛妛夛帍vol.嘨噦1丗3-7丆2011丏

13) 攼尨捈庽丄惣拞懞棽堦丄帥揷揟惗丄栧愳弐柧 丂丂丂丂丂丂丂
丂 擜嵶娗丒恡憻偺敪惗亅嵞惗偲堛椕亅 丂
丂 Nephrology Frontier Vol.10 No.3丗12-19丆2011丏

14) 扟岥媊揟丄師揷丂惤丄崄愳丂嫓丄帥揷揟惗丄岞暥媊梇丄桳堜丂孫丄彫椦栁恖 丂丂丂丂丂丂丂
丂 庒擭敪徢偍傛傃崅楊敪徢愐捙娭愡墛偺椪彴揑摿挜偺専摙 丂
丂 擔杮愐捙娭愡墛妛夛帍vol.嘨噦1丗43-49丆2011丏

15) 桳堜丂孫丄媑杮岾惗丄扟岥媊揟丄師揷丂惤丄帥揷揟惗丄岞暥媊梇丄彫椦栁恖 丂丂丂丂丂丂丂
丂 愐捙娭愡墛偺幘姵妶摦惈儌僯僞儕儞僌偵偍偗傞FDG-PET/CT桳梡惈偺専摙 丂
丂 擔杮愐捙娭愡墛妛夛帍vol.嘨噦1丗51-56丆2011丏

16) 彫徏憈巕丄扟岥媊揟丄愇嫶埢巕丄崄愳丂嫓丄帥揷揟惗丄岞暥媊梇丄嵅抾岹暥丄幏報懢榊丄媑塱懽旻 丂丂丂丂丂丂丂
丂 銷泖娻偵懳偡傞BCG椕朄偵傛傝敪徢偟偨斀墳惈娭愡墛偺堦椺 丂
丂 擔杮愐捙娭愡墛妛夛帍vol.嘨噦1丗113-119丆2011丏

17) 堜忋峢曘丄搰懞朏巕丄弿曽岻擇丄愇尨惓峴丄崄愳丂嫓丄帥揷揟惗 丂丂丂丂丂丂丂
丂 俙俲俬偺怴婯帯椕朄偺奐敪 丂
丂 恡憻vo1丏34 No2丗103-106丆2011丏

18) 崄愳丂嫓丄帥揷揟惗 丂丂丂丂丂丂丂
丂 儊僒儞僊僂儉憹怋惈巺媴懱恡墛[IgA恡徢, non-IgA恡徢] 丂
丂 暿嶜擔杮椪喱幮丂恡憻徢岓孮乮戞2斉乯噦17丗60-61丆2012丏

19) 弿曽岻擇丄搰懞朏巕丄堜忋峢曘丄崄愳丂嫓丄帥揷揟惗 丂丂丂丂丂丂丂
丂 娗撪憹怋惈巺媴戅懱恡墛 丂
丂 暿嶜擔杮椪喱幮丂恡憻徢岓孮乮戞2斉乯噦17丗74-75丆2012丏

20) 堜忋峢曘丄搰懞朏巕丄弿曽岻擇丄帥揷揟惗 丂丂丂丂丂丂丂
丂 僇儕僂儉憆幐惈恡徢 丂
丂 暿嶜擔杮椪喱幮丂恡憻徢岓孮乮戞2斉乯噦17丗811丆2012丏

21) 搰懞朏巕丄帥揷揟惗 丂丂丂丂丂丂丂
丂 僫僩儕僂儉憆幐惈恡徢 丂
丂 暿嶜擔杮椪喱幮丂恡憻徢岓孮乮戞2斉乯噦17丗821丆2012丏

1) Hanazaki K.
丂 Effect of nutritional intervention with branched chain amino acids on liver surgery: Current status and future
丂 perspectives.
丂 Scientific Symposium on the Hong Kong Society of Transplantation for "Hepato-Biliary-Pancreatic Surgery & Liver
丂 Transplantation Today", 2011.06, Hong Kong, China

2) Hanazaki K, Yatabe T, Munekage M, Ichikawa K, Kitagawa H, Yamashita K, Yokoyama M, Okabayashi T.
丂 Relationship between perioperative glycemic control and surgical site infection.
丂 EPS Montreal International Clinical Medicine Forum 2011, 2011.06, Montreal, Canada

3) Hanazaki K.
丂 Surgical treatment for chronic hepatitis B related hepatocellular carcinoma.
丂 2nd Annual Symposia Hepatitis Virus, 2011.07, Beijing, China

4) Hanazaki K.
丂 Hyperglycemia during hepatic ischemia-reperfusion period in patients undergoing hepatic resection: continuous
丂 monitoring blood glucose concentration using an artificial endocrine pancreas.
丂 8th Asian Congress Microcirculation (ACM-2011), 2011.10, Bangkok, Thailand

5) Hanazaki K, Okabayashi T, Namikawa T, Sugimoto T, Ichikawa K, Kitagawa H, Munekage M, Kobayshi M.
丂 Current nutritional support for ERAS.
丂 21st World Congress International Association Surgeons Gastroenterologists Oncologists, 2011.11, Tokyo, Japan

崙撪妛夛

1) 壀椦梇戝
丂 娞峝曄帯椕偵偍偗傞塰梴帯椕偺堄媊
丂 戞47夞擔杮娞憻妛夛憤夛妛弍廤夛, 2011.06, 搶嫗

2) 壴�睒a峅
丂 奜壢廃弍婜偺寣摐抣娗棟亅ERAS傪栚巜偟偨恖岺鋁憻傪梡偄偨廃弍婜寣摐娗棟亅
丂 戞49夞擔杮恖岺憻婍妛夛戝夛, 2011.11, 搶嫗

3) 帥揷揟惗丄堜忋峢曘丄崄愳丂嫓
丂 AKI偺擜嵶娗偺嵞惗婡彉偲崱屻偺揥奐
丂 戞54夞擔杮恡憻妛夛妛弍憤夛僔儞億僕僂儉丏6寧15擔丆2011丏墶昹丏

4) 捑丂暎丄搒棷塸旤丄栴惗寬堦丄戝敆梞帯丄捗揷夒擵丄慜揷挿惓
丂 儅僂僗枛徑寣桼棃偺寣塼姴嵶朎傪梡偄偨掅巁慺惈嫊寣惈擼徢偺帯椕儌僨儖
丂 戞10夞擔杮嵞惗堛椕妛夛憤夛丏2011擭3寧1擔乣2擔丆搶嫗丏

戞54夞擔杮恡憻妛夛妛弍憤夛乽桪廏墘戣徿乿 丂丂丂丂
媣丂夒峴乽BNIP3偼媫惈恡忈奞偵偍偄偰桿摫偝傟嬤埵擜嵶娗嵶朎偺Autophagy偲Apoptosis傪挷惍偡傞乿

1) Algorithm for Estimation of Thyroid Gland Size in Ultrasonography Images for Extracting Abnormal Thyroid in Medical
丂 Practice.
丂 Yutaka Hatakeyama, Hiromi Kataoka, Noriaki Nakajima, Teruaki Watabe, and Yoshiyasu Okuhara.
丂 Journal of Advanced Computational Intelligence and Intelligent Informatics. 2012, Vol.16 No.1, pp87-93

2) Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to
丂 2010 in Japan: a multicenter large retrospective study.
丂 Eguchi Y, Hyogo H, Ono M, Mizuta T, Ono N, Fujimoto K, Chayama K, Saibara T; JSG-NAFLD.
丂 J Gastroenterol. 2012 Feb 11. [Epub ahead of print] (IF: 3.610)

3) Usefulness of Technetium-99 m-2-methoxy-isobutyl-isonitrile liver scintigraphy for evaluating disease activity of non-
丂 alcoholic fatty liver disease.
丂 Masuda K, Ono M, Fukumoto M, Hirose A, Munekage K, Ochi T, Okamoto N, Akagi N, Ogawa Y, Saibara T.
丂 Hepatol Res. 2012 Mar;42(3):273-279. (IF: 1.858)

4) Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population.
丂 Sumida Y, Yoneda M, Hyogo H, Itoh Y, Ono M, Fujii H, Eguchi Y, Suzuki Y, Aoki N, Kanemasa K, Fujita K, Chayama K,
丂 Saibara T, Kawada N, Fujimoto K, Kohgo Y, Yoshikawa T, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver
丂 Disease (JSG-NAFLD).
丂 BMC Gastroenterol. 2012 Jan 5;12:2. (IF: 2.468)

5) Impact of ovarian sex steroids on ovulation and ovulatory gene induction in aromatase-null mice.
丂 Toda K, Hayashi Y, Ono M, Saibara T.
丂 Endocrinology. 2012 Jan;153(1):386-394. (IF: 4.993)

6) Angiotensinogen gene haplotype is associated with the prevalence of Japanese non-alcoholic steatohepatitis.
丂 Ono M, Ochi T, Munekage K, Ogasawara M, Hirose A, Nozaki Y, Takahashi M, Okamoto N, Saibara T.
丂 Hepatol Res. 2011 Dec;41(12):1223-1229. (IF: 1.858)

7) Serum dehydroepiandrosterone sulphate levels in patients with non-alcoholic fatty liver disease.
丂 Koga M, Saito H, Mukai M, Saibara T, Kasayama S.
丂 Intern Med. 2011;50(16):1657-1661. (IF: 1.037)

8) BART inhibits pancreatic cancer cell invasion by inhibiting ARL2-mediated RhoA inactivation.
丂 Taniuchi K, Iwasaki S, Saibara T.
丂 Int J Oncol. 2011 Nov;39(5):1243-1252. (IF: 2.571)

9) Platelet count for predicting fibrosis in nonalcoholic fatty liver disease.
丂 Yoneda M, Fujii H, Sumida Y, Hyogo H, Itoh Y, Ono M, Eguchi Y, Suzuki Y, Aoki N, Kanemasa K, Imajo K, Chayama K,
丂 Saibara T, Kawada N, Fujimoto K, Kohgo Y, Yoshikawa T, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver
丂 Disease.
丂 J Gastroenterol. 2011 Nov;46(11):1300-1306. (IF: 3.610)

10) Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth.
丂 Taniuchi K, Cerny RL, Tanouchi A, Kohno K, Kotani N, Honke K, Saibara T, Hollingsworth MA.
丂 Oncogene. 2011 Dec 8;30(49):4843-4854. (IF: 7.414)

11) A novel and comprehensive mouse model of human non-alcoholic steatohepatitis with the full range of dysmetabolic
丂 and histological abnormalities induced by gold thioglucose and a high-fat diet.
丂 Ogasawara M, Hirose A, Ono M, Aritake K, Nozaki Y, Takahashi M, Okamoto N, Sakamoto S, Iwasaki S, Asanuma T,
丂 Taniguchi T, Urade Y, Onishi S, Saibara T, Oben JA.
丂 Liver Int. 2011 Apr;31(4):542-551. (IF: 1.858)

12) Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma.
丂 Yasui K, Hashimoto E, Komorizono Y, Koike K, Arii S, Imai Y, Shima T, Kanbara Y, Saibara T, Mori T, Kawata S, Uto H,
丂 Takami S, Sumida Y, Takamura T, Kawanaka M, Okanoue T; Japan NASH Study Group, Ministry of Health, Labour,
丂 and Welfare of Japan.
丂 Clin Gastroenterol Hepatol. 2011 May;9(5):428-433 (IF: 5.286)

13) Intracellular CD24 inhibits cell invasion by posttranscriptional regulation of BART through interaction with G3BP.
丂 Taniuchi K丆Nishimori I丆Hollingsworth MA.
丂 Cancer Res. 2011 Feb 1;71(3):895-905. (IF: 8.438)

14) The N-terminal domain of G3BP enhances cell motility and invasion by posttranscriptional regulation of BART.
丂 Taniuchi K丆Nishimori I丆Hollinsworth MA.
丂 Mol Cancer Res. 2011 Jul;9(7):856-866. (IF: 4.373)

15) A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in
丂 nonalcoholic fatty liver disease.
丂 Sumida Y, Yoneda M, Hyogo H, Yamaguchi K, Ono M, Fujii H, Eguchi Y, Suzuki Y, Imai S, Kanemasa K, Fujita K,
丂 Chayama K, Yasui K, Saibara T, Kawada N, Fujimoto K, Kohgo Y, Okanoue T: Japan Study Group of Nonalcoholic
丂 Fatty Liver Disease (JSG-NAFLD).
丂 J Gastroenterol. 2011; 46: 257-268 (IF: 3.610)

1) 墱尨媊曐
丂丂丂丂丂丂丂
丂 HIS僨乕僞2師棙梡偵傛傞僔僗僥儉惍旛偺壽戣偲曽嶔 丂
丂 寧姧怴堛椕2011擭11寧崋丄p41-p44

1) Combined measurements of cardiac troponin I and brain natriuretic peptide are useful for predicting adverse
丂 outcomes in hypertrophic cardiomyopathy.
丂 Kubo T, Kitaoka H, Okawa M, Yamanaka S, Hirota T, Baba Y, Hayato K, Yamasaki N, Matsumura Y, Yasuda N,
丂 Sugiura T, Doi YL.
丂 Circ J. 2011;75(4):919-926. (IF: 3.225)

2) What is a common factor in different areas? : The case of depression among caregivers of the frail elderly in Sapporo
丂 and Kochi, Japan.
丂 Oura A, Mori M, Yasuda N, Miyano I, Izumi H, Washio M.
丂 Geriatr Gerontol Int. 2012 Apr;12(2):230-237. (IF: 1.782)

3) Limonene Inhalation Reduces Allergic Airway Inflammation in Dermatophagoides farinae-treated Mice.
丂 Hirota R, Nakamura H, Bhatti SA, Ngatu NR, Muzembo BA, Dumavibhat N, Eitoku M, Sawamura M, Suganuma N.
丂 Inhal Toxicol. 2012. In press (IF: 2.295)

4) Case Report: Asbestos-Related Diseases in Thailand and Review Literature.
丂 Subhannachart P, Dumavibhat N, Siriruttanapruk S.
丂 Journal Medical Association of Thailand. 2012. In press (IF: No data)

5) Proficiency in Reading Pneumoconiosis Radiographs Examined by the 60-film Set with 4-factor Structuring 8-index.
丂 Zhou H, Kusaka Y, Tamura T, Suganuma N, Subhannachart P, Siriruttanapruk S, Dumavibhat N, Zhang X,
丂 Sishodiya PK, VAN Duy K, Hering KG, Parker JE, Algranti E, Fedotov I, Shida H, Akira M.
丂 Ind Health. 2012 Feb 3. [Epub ahead of print] (IF: 0.950)

6) The 60-film Set with 8-index for Examining Physicians' Proficiency in Reading Pneumoconiosis Chest X-rays.
丂 Zhou H, Kusaka Y, Tamura T, Suganuma N, Subhannachart P, Siriruttanapruk S, Dumavibhat N, Zhang X,
丂 Sishodiya PK, VAN Duy K, Hering KG, Parker JE, Algranti E, Fedotov I, Shida H, Akira M.
丂 Ind Health. 2012 Apr 13;50(2):84-94. (IF: 0.950)

7) Anti-inflammatory effects of sacran, a novel polysaccharide from Aphanothece sacrum, on 2,4,6-trinitrochlorobenzene
丂 -induced allergic dermatitis in vivo.
丂 Ngatu NR, Okajima MK, Yokogawa M, Hirota R, Eitoku M, Muzembo BA, Dumavibhat N, Takaishi M, Sano S, Kaneko T,
丂 Tanaka T, Nakamura H, Suganuma N.
丂 Ann Allergy Asthma Immunol. 2012 Feb;108(2):117-122. (IF: 2.801)

8) Brazilian green propolis extracts improve Tinea pedis interdigitalis and Tinea corporis.
丂 Ngatu NR, Saruta T, Hirota R, Eitoku M, Luzitu NS, Muzembo BA, Matsui T, Suganuma N.
丂 J Altern Complement Med. 2012 Jan;18(1):8-9. (IF: 1.498)

9) Assessment of lifestyle effect on oxidative stress biomarkers in free-living elderly in rural Japan.
丂 Muzembo BA, Narongpon D, Ngatu NR, Eitoku M, Hirota R, Suganuma N.
丂 Geriatr Gerontol Int. 2011 Dec 28.[Epub ahead of print] (IF: 1.782)

10) Antifungal Efficacy of Brazilian green propolis extracts and Honey on Tinea capitis and Tinea versicolor.
丂 Ngatu NR, Saruta T, Hirota R, Eitoku M, Muzembo BA, Matsui T, Nangana LS, Mbenza MA, Kumagai N, Suganuma N.
丂 European Journal of Integrative Medicine. 2011 Oct 24;3:e281-e287. (IF: 1.200)

11) Perception of the risk of sexual transmission of HIV among Congolese and Japanese university students.
丂 Ngatu NR, Hirota R, Eitoku M, Muzembo BA, Nishimori M, Kuramochi M, Shintani S, Inoue S, Takiuchi R, Maegawa M,
丂 Ribble D, Mbenza MA, Situakibanza NT, Mbanzulu PD, Suganuma N.
丂 Environ Health Prev Med. 2012 Mar;17(2):139-46. (IF: No data)

12) Goishi tea consumption inhibits airway hyperresponsiveness in BALB/c mice.
丂 Hirota R, Ngatu NR, Miyamura M, Nakamura H, Suganuma N.
丂 BMC Immunol. 2011 Aug 11;12:45. (IF: 3.000)

13) Practice of universal precautions and risk of occupational blood-borne viral infection among Congolese health care
丂 workers.
丂 Ngatu NR, Phillips EK, Wembonyama OS, Hirota R, Kaunge NJ, Mbutshu LH, Perry J, Yoshikawa T, Jagger J,
丂 Suganuma N.
丂 Am J Infect Control. 2012 Feb;40(1):68-70.e1. (IF: 3.036)

挊彂

1) Ngatu NR, Kayembe NJM, Longo-Mbenza B, Suganuma N.
丂 The Pneumoconioses.
丂 Lung Diseases - Selected State of the Art Reviews (Irusen EM), 625-646 (Chapter 29), InTech, Rijeka(Croatia), 2012

弌婅

1)PCT/JP2011/061910丄傾僩僺乕惈旂晢墛偺梊杊嵻傑偨偼帯椕嵻
丂 峅揷検擇丄僈僢僣 儔儞僪僁 儘僕儍乕丄2011擭5寧24擔

2)摿奐2012-20278丄懡娐朏崄懓扽壔悈慺偺彍嫀曽朄
丂 峅揷検擇丄悰徖惉暥丄2011擭3寧3擔

1) Dumavibhat N. 丂
丂 AIR Pneumo program upgrading physicians乫skill for reading radiographs of pneumoconiosis.
丂 The 30th International Congress on Occupational Health, 2012擭3寧18擔-23擔, Cancun, Mexico

崙撪妛夛

1) 悰徖惉暥
丂 悽奅偺堊偵惗偒傞乣巹偺挧愴乣 Living for the world: My challenge乮妛夛挿島墘乯
丂 戞俁侽夞擔杮崙嵺曐寬堛椕妛夛惣擔杮抧曽夛丄2012擭3寧3擔丄崅抦導乮崅抦戝妛乯

2) 撿傑傝側丄悰徖惉暥
丂 偙偆偪僄僐僠儖挷嵏偺儕僋儖乕僩忬嫷
丂 戞俇侾夞崅抦嶻壢晈恖壢妛夛妛弍廤夛丄2011擭12寧23擔丄崅抦導

3) 悰徖惉暥
丂 怑嬈惈屇媧婍昦偺夋憸恌抐偺曄慗乮妛夛挿島墘乯
丂 戞俆俆夞拞崙巐崙崌摨嶻嬈塹惗妛夛丄2011擭12寧11擔丄崅抦導

4) 悰徖惉暥
丂 僄僐僠儖偵偮偄偰
丂 戞俀俋夞擔杮惗棟怱棟妛夛戝夛丄2011擭5寧21擔丄崅抦導

1) Ngatu NR.
丂 暯惉23擭搙 崅抦戝妛尋媶尠彶惂搙戝妛堾惗尋媶彠椼徿. 2012.

2) Ngatu NR.
丂 戞11夞 KMS儕僒乕僠儈乕僥傿儞僌桪廏徿. 2012.

悰徖惉暥

丂 1) 偼偨傕乕傜乮暯惉23擭4寧崋宖嵹乯丂僄僐僠儖徯夘戞1夞栚

丂 2) 崅抦怴暦乮暯惉23擭4寧7擔宖嵹乯丂 挷嵏恑捇忬嫷

丂 3) 戝妛峀曬帍乮暯惉23擭4寧乯丂丂丂丂2011弔崋丄僄僐僠儖徯夘

丂 4) 俼俲俠崅抦曻憲俿倁乽RKC揱尵斅乿乮暯惉23擭4寧18擔曻憲乯 嶲壛幰僀儞僞價儏乕

丂 5) 崅抦導嶻晈恖壢堛曬乮暯惉23擭5寧27擔宖嵹乯 戞俇侽夞擔杮嶻壢晈恖壢妛夛崅抦抧曽晹夛妛弍島墘夛丒摿暿島墘梫巪

丂 6) 婫姧崅抦乮暯惉23擭6寧25擔敪攧乯丂僄僐僠儖徯夘

丂 7) 偼偨傕乕傜乮暯惉23擭7寧崋宖嵹乯丂 僄僐僠儖徯夘戞2夞栚

丂 8) 峀曬巐枩廫乮暯惉23擭7寧崋 No.75乯 巐枩廫巗丗僄僐僠儖徯夘

丂 9) 峀曬備偡偼傜乮暯惉23擭7寧崋 No.637乯搸尨挰丗僄僐僠儖徯夘

丂10) 崅抦怴暦乮暯惉23擭7寧23擔宖嵹乯丂挷嵏奐巒敿擭偺恑捇忬嫷偲塣塩嫤媍夛曬崘

丂11) 俶俫俲憤崌乽偍偼傛偆偙偆偪乿乮暯惉23擭7寧27擔曻憲乯僄僐僠儖挷嵏敿擭忬嫷丄弌嶻奐巒曬崘

丂12) 戝妛峀曬帍乮暯惉23擭7寧乯丂丂丂丂2011壞崋丄僄僐僠儖徯夘

丂13) 峀曬側傫偙偔乮暯惉23擭8寧崋 No.823乯撿崙巗丗僄僐僠儖徯夘

丂14) 峀曬偁偐傞偄傑偪乮暯惉23擭8寧崋 No.698乯崅抦巗丗僄僐僠儖徯夘

丂15) 崅抦怴暦乮暯惉23擭8寧4擔宖嵹乯丂乽惡傂傠偽乿嫤椡堛椕婡娭偐傜偺徯夘婰帠

丂16) 俲倀俿倁僥儗價崅抦乽儂僢僩崘抦斅乿乮暯惉23擭9寧6擔曻憲乯嶲壛幰1000恖払惉曬崘

丂17) 崅抦導堛巘夛曬乮暯惉23擭10寧1擔宖嵹乯亀堛巘偐丄堛巘偱偼側偄偐丄偦傟偑栤戣丠亁

丂18) 偼偨傕乕傜乮暯惉23擭10寧崋宖嵹乯丂僄僐僠儖徯夘戞3夞栚

丂19) 傎偭偲偙偆偪乽儅儅偺杮乿乮暯惉23擭10寧10擔敪攧乯丂僄僐僠儖徯夘

丂20) 崅抦怴暦乮暯惉23擭10寧15擔宖嵹乯崅抦戝妛堛妛晹晬懏昦堾30廃擭婰擮帠嬈

丂21) 俼俲俠崅抦曻憲俿倁乽偛偒偘傫Bonito偭両両乿乮暯惉23擭10寧29擔曻憲乯挷嵏恑捇忬嫷丄嶲壛幰僀儞僞價儏乕

丂22) 戝妛峀曬帍乮暯惉23擭10寧乯2011廐崋丄嶲壛幰1000恖払惉曬崘

丂23) 峀曬偁偐傞偄傑偪乮暯惉23擭11寧崋 No.701乯崅抦巗丗僄僐僠儖徯夘

丂24) 俼俲俠崅抦曻憲俿倁乽偙偆偪eye乿乮暯惉23擭11寧15擔曻憲乯偙偆偪僄僐僠儖挷嵏丂崙嵺僔儞億僕僂儉

丂25) 傎偭偲偙偆偪乽jurer/僕儏儗乿乮暯惉23擭12寧25擔敪攧乯 僄僐僠儖挷嵏偵偮偄偰丒恑捇忬嫷

丂26) 偼偨傕乕傜乮暯惉24擭1寧崋宖嵹乯丂僄僐僠儖挷嵏偵偮偄偰丒恑捇忬嫷

丂27) 戝妛峀曬帍乮暯惉24擭1寧乯丂丂丂丂崙嵺僔儞億僕僂儉奐嵜曬崘

丂28) 崅抦怴暦乮暯惉24擭1寧25擔宖嵹乯丂Ngatu NR, Hirota R, 崅抦敪傾僩僺乕帯椕傪

丂29) 俲倀俿倁僥儗價崅抦乽儂僢僩崘抦斅乿乮暯惉24擭1寧31擔曻憲乯1廃擭僀儀儞僩崘抦

丂30) 峀曬偁偐傞偄傑偪乮暯惉24擭2寧崋 No.704乯僄僐僠儖恑捇忬嫷丒僀儀儞僩埬撪

丂31) 峀曬巐枩廫乮暯惉24擭2寧崋 No.82乯 丂僄僐僠儖恑捇忬嫷丒僀儀儞僩埬撪

丂32) 峀曬備偡偼傜乮暯惉24擭2寧崋 No.644乯僄僐僠儖恑捇忬嫷丒僀儀儞僩埬撪

丂33) 俼俲俠崅抦曻憲俿倁乽RKC揱尵斅乿乮暯惉24擭2寧6擔曻憲乯 1廃擭僀儀儞僩崘抦

丂34) 俶俫俲憤崌乽偙偆偪忣曬偄偪偽傫乿乮暯惉24擭2寧8擔曻憲乯Ngatu NR, 傾僩僺乕帯椕偵偐偗傞僐儞僑恖堛巘

丂35) 俲俽俽偝傫偝傫僥儗價乽偝傫偝傫PickUp乿乮暯惉24擭2寧13擔曻憲乯 1廃擭僀儀儞僩崘抦

丂36) 俶俫俲憤崌乽偙偆偪忣曬偄偪偽傫乿乮暯惉24擭2寧23擔曻憲乯 1廃擭僀儀儞僩崘抦乮侾夞栚乯

丂37) 俶俫俲憤崌乽偙偆偪忣曬偄偪偽傫乿乮暯惉24擭2寧24擔曻憲乯 1廃擭僀儀儞僩崘抦乮俀夞栚乯

丂38) 崅抦怴暦乮暯惉24擭2寧24擔宖嵹乯乽偲偝僩僺乿1廃擭僀儀儞僩崘抦

丂39) 俼俲俠崅抦曻憲儔僕僆乽傒傫側偺儔僕僆乿乮暯惉24擭2寧24擔曻憲乯 1廃擭僀儀儞僩僷僱儕僗僩弌墘

丂40) 俼俲俠崅抦曻憲俿倁乽偙偆偪eye乿乮暯惉24擭2寧25擔曻憲乯 1廃擭僀儀儞僩曬摴

丂41) 傎偭偲偙偆偪乽昦堾僈僀僪乿乮暯惉24擭2寧25擔敪攧乯 僄僐僠儖挷嵏1廃擭丒恑捇曬崘

丂42) 崅抦怴暦乮暯惉24擭2寧26擔宖嵹乯 1廃擭僀儀儞僩曬摴

丂43) 俲俽俽偝傫偝傫僥儗價乽SUNSUN僗乕僷乕僯儏乕僗乿乮暯惉24擭2寧27擔曻憲乯 1廃擭僀儀儞僩曬摴

丂44) 峀曬側傫偙偔乮暯惉24擭3寧崋 No.830乯 僄僐僠儖挷嵏1廃擭丒恑捇曬崘

偦偺懠偺妶摦

亂堦斒岦偗僀儀儞僩奐嵜亃
丂丂僄僐僠儖挷嵏僼傽乕僗僩傾僯僶乕僒儕乕僀儀儞僩
丂丂亀崱丄偡偙傗偐側娐嫬偲偼乣偙偳傕偨偪偺傛傝傛偄枹棃偺偨傔偵乣亁
丂丂僾儘僌儔儉嘆丗乽弡偺怘嵽傪巊偭偨僄僐丒僋僢僉儞僌乿
丂丂島巘丗扟岥峕棙崄
丂丂僾儘僌儔儉嘇丗乽僄僐丒僩乕僋僔儑乕乿
丂丂嶲壛幰丗僕儑儞丒儉乕傾丄堜忋恀桼旤丄悰徖惉暥
丂丂擔帪丗2012擭2寧25擔
丂丂応強丗崅抦巗

亂巗柉岞奐島嵗亃
丂丂亀崱丄側偤怘堢偐丠亁
丂丂乣娐嫬偲寬峃傪峫偊傞 in 崅抦乣丂巕偳傕偺寬峃偲枹棃傪峫偊傞
丂丂婎挷島墘
丂丂僎僗僩丗塆朮巕揷彶丄暈晹岾滀丄嶰殸惔嶰丄庴揷峗擵丄悰徖惉暥
丂丂僷僱儖僨傿僗僇僢僔儑儞
丂丂擔帪丗2011擭10寧23擔
丂丂応強丗崅抦巗

丂丂亀僾儘億儕僗丄偼偪傒偮揾晍偺旂晢幘姵夵慞亁
丂丂嶳揷梴朓応丂傒偮偽偪尋媶彆惉婎嬥丂寬峃僙儈僫乕
丂丂墘幰丗Ngatu NR.
丂丂応強丗壀嶳巗

亂崙嵺楢実亃
丂1) 2012擭3寧16擔乣24擔
丂丂 僀僄乕僥儃儕戝妛僊儖僶乕僌攷巑朘栤
丂丂 悰徖惉暥丄埨岝儔償僃儖崄曐巕
丂丂 島巘丗扟岥峕棙崄
丂丂 僾儘僌儔儉嘇丗乽僄僐丒僩乕僋僔儑乕乿
丂丂 嶲壛幰丗僕儑儞丒儉乕傾丄堜忋恀桼旤丄悰徖惉暥
丂丂 擔帪丗2012擭2寧25擔
丂丂 応強丗崅抦巗
丂2) 2011擭11寧16擔乣17擔
丂丂 僀僄乕僥儃儕戝妛僊儖僶乕僌攷巑棃崅
丂丂 悰徖惉暥丄埨岝儔償僃儖崄曐巕
丂丂 乮尋媶懪崌偣丄導庡嵜偺島墘夛捠栿乯

亂嫵堢僐乕僗亃
丂1) Dumavibhat N.
丂丂 Review of Large Opacity and Additional Symbol
丂丂 The 1st AIR Pneumo Course in Japan, 2011擭9寧2擔-4擔丄搶嫗搒
丂2) Dumavibhat, N.
丂丂 Large Opacity.
丂丂 The 2nd ILO/AIR Pneumo Project Training Workshop on Asian Intensive Reading of Radiographs for
丂 丂Pneumoconioses, 2010擭12寧20擔-22擔, Bangkok, Thailand

亂僙儈僫乕亃
丂1) 峅揷検擇
丂丂 撿崙搚嵅偐傜傗偭偰偒備偆丄寬峃偵偊偄丄桪傟偪傘偆怉暔偺偼側偟
丂丂 儅僥儕傾儖僒僀僄儞僗尋媶壢僙儈僫乕丄2011擭7寧26擔丄愇愳導乮杒棨愭抂壢妛媄弍戝妛堾戝妛乯
丂2) Ngatu NR, Hirota R.
丂丂 Bioactive properties of Vernonia amygdalina leaf extracts on skin allergic disorders.
丂丂 儅僥儕傾儖僒僀僄儞僗尋媶壢僙儈僫乕丄2011擭7寧26擔丄愇愳導乮杒棨愭抂壢妛媄弍戝妛堾戝妛乯
丂3) Dumavibhat N.
丂丂 Pneumoconiosis - an underdiagnosed disease in Thailand.
丂丂 The 1404th Chest Conference imaging of Lung and Pleura, 2010擭12寧16擔-17擔, Phuket, Thailand

1) Effects of various doses of aspirin on platelet activity and endothelial function.
丂 Furuno T, Yamasaki F, Yokoyama T, Sato K, Sato T, Doi Y, Sugiura T.
丂 Heart Vessels. 2011 May;26(3):267-273. (IF: 1.882)

2) Feasibility of ICG fluorescence-guided sentinel node biopsy in animal models using the HyperEye Medical System.
丂 Yamauchi K, Nagafuji H, Nakamura T, Sato T, Kohno N.
丂 Ann Surg Oncol. 2011 Jul;18(7):2042-2047. (IF: 4.182)

3) Donepezil, anti-Alzheimer's disease drug, prevents cardiac rupture during acute phase of myocardial infarction in
丂 mice.
丂 Arikawa M, Kakinuma Y, Handa T, Yamasaki F,Sato T.
丂 PLoS One. 2011;6(7):e20629. (IF: 4.411)

4) Assessing intraoperative blood flow in cardiovascular surgery.
丂 Yamamoto M, Sasaguri S, Sato T.
丂 Surg Today. 2011 Nov;41(11):1467-1474. (IF: 1.057)

5) Conditional VHL gene deletion activates a local NO-VEGF axis in a balanced manner reinforcing resistance to
丂 endothelium-targeted glomerulonephropathy.
丂 Morita T, Kakinuma Y, Kurabayashi A, Fujieda M, Sato T, Shuin T, Furihata M, Wakiguchi H.
丂 Nephrol Dial Transplant. 2011 Dec;26(12):4023-4031. (IF: 3.564)

6) Nociceptive sensory innnervation of the posterior cruciate ligament in osteoarthritic knees.
丂 Ikeuchi M, Wang Q, Izumi M, Tani T.
丂 Arch. Orthop. Trauma Surg. 2012 Feb 19. [Epub ahead of print] (IF: 1.196)

7) Maximum voluntary ventilation as a sensitive measure to monitor the ventilatory function in cervical spondylotic
丂 myelopathy.
丂 Nomura T, Tani T, Ikeuchi M, Akutagawa T, Enoki H, Ishida K.
丂 Spinal Cord. 2012 Apr;50(4):328-332. (IF: 1.826)

8) Dangerous cervical radiculopathy by Lemierre乫s syndrome.
丂 Ikemoto T, Kawasaki M, Kato T, Takemasa R, Ushida T, Tani T, Taniuchi K.
丂 J Orthp Sci. 2011 Jun 4. [Epub ahead of print] (IF: 0.839)

9) Risk factor analysis of curve progression in early degenerative lumbar scoliosis: a minimum follow-up of 10 years.
丂 Kohno S, Ikeuchi M, Taniguchi S, Takemasa R, Yamamoto H, Tani T.
丂 J Orthop Surg. 2011 19(2): 141-144.

10) Effect of volitional relaxation and motor imagery on F wave and MEP: Do these tasks affect excitability of the spinal
丂 or cortical motor neurons?
丂 Fujisawa R, Kimura J, Taniguchi S, Ichikawa H, Hara M, Shimizu H, Iida H, Yamada T, Tani T.
丂 Clin Neurophysiol. 2011 Jul;122(7):1405-1410. (IF: 2.786)

11) Control of an Omnidirectional Walking Support Walker by Forearm Pressures.
丂 Yinlai Jiang, Shuoyu Wang, Renpeng Tan, Kenji Ishida, Takeshi Ando and Masakatsu G. Fujie.
丂 Conf Proc IEEE Eng Med Biol Soc.2011;2011:7466-7469.

挊彂

1) Sato T, Diedrich A, Sunagawa K.
丂 Bionic Baroreflex.
丂 PRIMER ON THE AUTONOMIC NERVOUS SYSTEM 3nd ed. (In: Robertson D et al. editors.) p.659-662.
丂 Elsevier Academic Press, USA, 2012.

2) 搉嫶榓惌
丂 宱怘摴怱僄僐乕朄儅僯儏傾儖
丂 351暸丆撿峕摪丆搶嫗丆2012擭
丂 晅懏偺俢倁俢偵TEE-SIM偲偄偆宱怘摴怱僄僐乕僩儗乕僯儞僌梡僔儈儏儗乕僔儑儞僜僼僩傪廂榐

1) Patent No.:US 7,962,216 B2, 乬CARDIAC PACING SYSTEM, BLOOD PRESSURE REGULATING SYSTEM, AND CARDIAC
丂 DISEASE TREATMENT SYSTEM BY SUBSTITUTING NATIVE BIOLOGICAL REGULATORY FUNCTION乭
丂 Kenji Sunagawa, Masaru Sugimachi, Takayuki Sato, Jun.14,2011.

2) 摿嫋戞4872044崋乽怱憻儕儌僨儕儞僌梷惂栻偍傛傃怱晄慡帯椕栻乿
丂 敪柧幰丗悪挰丂彑丄棝丂攡壴丄 揂丂嶹丄嵅摗棽岾丄嵒愳尗擇丂搊榐擔: 2011.12.2.

3) 摿嫋戞4888856崋乽嫊寣惈幘姵偵懳偡傞寣娗怴惗懀恑帯椕栻乿
丂 敪柧幰丗拞嶳懽廏丄嵅摗棽岾丂搊榐擔: 2011.12.22.

崙撪妛夛

1) 愇揷寬巌
丂 乽崅楊幰儘僐儌僥傿僽僔儞僪儘乕儉偵懳偡傞塣摦椕朄乿
丂 戞116夞拞晹擔杮惍宍奜壢嵭奞奜壢妛夛丂嫵堢尋廋島墘丂2011.4.8.崅抦

2) 愇揷寬巌
丂 乽儘僐儌梊杊偲儊僞儃梊杊丂丂堦弿偵側偭偰尦婥偱挿惗偒乿
丂 擔杮塣摦婍壢妛妛夛丂嫵堢尋廋島墘丂2011.4.17丂壀嶳

3) 愇揷寬巌
丂 乽抧堟偱峴偆夘岇梊杊傊偺墖彆丒巜摫丂乕塣摦婍偺婡擻岦忋傪拞怱偵乕乿
丂 擔杮惍宍奜壢妛夛丂拞崙巐崙嫵堢尋廋島墘丂2011.7.10.丂摽搰

曬摴

嵅摗棽岾

1)乽僗僋乕僷乕 SCOOPER乿擔杮僥儗價偺愭抂壢妛媄弍徯夘斣慻
丂 杮妛偱奐敪偟偨僴僀僷乕丒傾僀丒儊僨傿僇儖僔僗僥儉偺徯夘 2012.1.27. 丂丂
丂

偦偺懠偺妶摦

亂島墘亃
丂1) 乽嬤愒奜岝僇儔乕僀儊乕僕儞僌憰抲偲嬤愒奜寀岝僪儔僢僌丒僨僶僀僗傪梡偄偨嬤枹棃庤弍乿
丂丂 嵅摗棽岾
丂丂 VISION丂Japan2011. 僷僔僼傿僐墶昹. 墶昹巗. 2011.4.20-22.
丂2) 乽嬤愒奜寀岝僇儔乕僀儊乕僕儞僌僔僗僥儉傪梡偄偨弍拞僫價僎乕僔儑儞乿
丂丂 嵅摗棽岾
丂丂 暯惉23擭搙戞1夞師悽戙僶僀僆僫僲尋媶夛. 嶻嬈媄弍憤崌尋媶強丂巐崙僙儞僞乕島摪. 崅徏巗. 2011.9.26.

亂嶨帍亃
丂1) 嬤愒奜寀岝庤弍拞僫價僎乕僔儑儞僇儔乕僀儊乕僕儞僌僔僗僥儉.
丂丂 嵅摗棽岾
丂丂 崅抦戝妛堛妛晹丒堛妛晹晬懏昦堾丂奣梫乮2011擭4寧乯
丂2) 柌拞偵側傞岾偣-悽奅弶偺庤弍僫價僔僗僥儉傪奐敪両栚巜偡偺偼埨慡側堛椕.
丂丂 嵅摗棽岾
丂丂 崅抦戝妛2012戝妛埬撪. (2011擭6寧敪峴)
丂3) 栚偵尒偊側偄姵晹偑帇偊傞僴僀僷乕傾僀僇儊儔偺奐敪.
丂丂 嵅摗棽岾
丂丂 崅抦戝妛昦堾僯儏乕僗丂戞140崋 崅抦戝妛昦堾峀曬丂偙偼偡偔傫(2011擭8寧)
丂4) 嬤愒奜慄傪棙梡偟偨惗懱偺壜帇壔.
丂丂 嵅摗棽岾
丂丂 Medical Photonics No.7 p53-57.乮2011.廐崋)
丂5) 嬤愒奜岝偺堛椕墳梡-奜壢堛傪僒億乕僩偡傞塮憸媄弍.
丂丂 嵅摗棽岾
丂丂 夋憸儔儃丂2012; 23: 9-13. (2012.3寧崋)

1) Metabolomics Study on the Biochemical Profiles of Odor Elements in Urine of Human with Bladder Cancer.
丂 Kohei Jobu, Changhai Sun, Sabro Yoshioka, Junko Yokota, Masahide Onogawa, Chiaki Kawada, Keiji Inoue,
丂 Taro Shuin, Toshiaki Sendo, Mitsuhiko Miyamura.
丂 Biol. Pharm. Bull. 2012;35(4):639-642. (IF: 1.81)

2) Goishi Tea Consumption Inhibits Airway Hyperresponsiveness in BALB/c Mice.
丂 Hirota R, Ngatu NR, Miyamura M, Nakamura H, Suganuma N.
丂 BMC Immunol. 2011 Aug 11, 12, pp45. (IF: 3.00)

3) Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of
丂 photodynamic diagnosis for nonmuscle invasive bladder cancer.
丂 Inoue K, Fukuhara H, Shimamoto T, Kamada M, Iiyama T, Miyamura M, Kurabayashi A, Furihata M, Tanimura M,
丂 Watanabe H, Shuin T.
丂 Cancer. 2012 Feb 15, 118(4), 1062-1074 (IF: 5.13)

4) Evaluation of Changes in Tumor Shadows and Microcalcifications on Mammography Following KORTUC II, a New
丂 Radiosensitization Treatment without any Surgical Procedure for Elderly Patients with Stage I and II Breast Cancer.
丂 Akira Tsuzuki, Yasuhiro Ogawa, Kei Kubota, Shiho Tokuhiro, Ryo Akima, Shin Yaogawa, Itoh Kenji, Yoko Yamada,
丂 Toshikazu Sasaki, Masahide Onogawa, Tomoaki Yamanishi, Shinji Kariya, Munenobu Nogami, Akihito Nishioka,
丂 Mitsuhiko Miyamura.
丂 Cancers. 2011, 3(3), 3496-3505.

5) Eriobotrya japonica seed extract and deep sea water protect against indomethacin-induced gastric mucosal injury in
丂 rats.
丂 Yokota J, Kitaoka T, Jobu K, Takuma D, Hamada A, Onogawa M, Yoshioka S, Kyotani S, Miyamura M.
丂 J Nat Med. 2011; 65: 9-17 (IF: 1.027)

6) Ameliorative effects of Eriobotrya japonica seed extract丂on cellular aging in cultured rat fibroblasts.
丂 Muramoto K, Quan R, Namba T, Kyotani S, Miyamura M, Nishioka Y, Tonosaki K, Doi Y, Kaba H.
丂 J Nat Med. 2011; 65: 254-261 (IF: 1.027)

7) View and present status of personnel involved in clinical trials: a survey of participants from the First Symposium of
丂 Shikoku Collaborative Group for Promotion of Clinical Trials.
丂 Yanagawa H, Lrahara M, Houchi H, Kakehi Y, Moritoyo T, Nomoto M, Miyamura M, Shuin T, & the Shikoku
丂 Collaborative Group for Promotion of Clinical Trials.
丂 J Med Invest. 2011; 58: 81-85

挊彂

1) 媨懞廩旻
丂 堛椕尰応偵偍偗傞堛椕忣曬娗棟
丂 �堛栻昳忣曬妛乗婎慴偐傜椪彴傊�壀栰慞榊丄219-223丄淎愳彂揦丂搶嫗丂2012.

1) 摿婅2011-269983 銷泖娻偺應掕曽朄丄傑偨偼娻帯椕屻偺梊屻偺敾掕曽朄
丂 媨懞廩旻丄忢晽嫽暯丄墶揷弤巕丄彫栰愳 夒塸丄媑壀嶰榊丄堜忋孾巎丄幏報懢榊丄曅壀峗枻丄孎扟捈巕丄暯惉23擭12寧9擔

崙嵺妛夛

1) 媨懞廩旻
丂 Pharmacy Higher Education in Japan
丂 Huachiew Chalermprakiet University(壺嫛悞惞戝妛), Thailand Bangkok

2) 媨懞廩旻
丂 Role of Pharmacists in Pharmaceutical Services in Japan
丂 2011.8.5 , Community Pharmacy Association, Thailand Bangkok

曬摴

媨懞廩旻

1)�岄愇拑偱僀儞僼儖梊杊丂崅抦戝妛偲戝朙挰偑嫟摨尋媶�
丂 2012擭3寧15擔丂崅抦怴暦 丂丂
丂